Government likely to restrict co-bioequivalence testing

The restriction of joint or consigned bioequivalence testing will not be lifted, according to informed sources.

The sources say the Korea Food and Drug Administration will determine the delay or abolition of the issue at the end of this month, despite the fact that the agency has called on local pharmaceutical companies to conduct their own bioequivalence testing to raise their transparency....